CRES-101

N/A

Report date: 2024/05/08 10:19:51

Base Information

Drug NameCRES-101
Drug Alias NameCRES-101BDX-101
ClassificationBiologics
Mechanisms of ActionMyelin proteins stimulants
TargetsMyelin proteins
Therapy Area/IndicationsOptic NeuritisPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingGuillain-Barre Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCresence AS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioasis Technologies Inc
Active IndicationsN/A
Inactive IndicationsOptic NeuritisPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingGuillain-Barre Syndrome

Other Information

ATC CodeN/A
Related LinksN/A